Non-used cryopreserved sperm among oncological patients: extra-long-term follow-up and analysis.
Cancer
Demographic characteristics
Sperm bank
Sperm cryopreservation
Sperm usage
Journal
Journal of assisted reproduction and genetics
ISSN: 1573-7330
Titre abrégé: J Assist Reprod Genet
Pays: Netherlands
ID NLM: 9206495
Informations de publication
Date de publication:
16 Oct 2024
16 Oct 2024
Historique:
received:
05
06
2024
accepted:
03
10
2024
medline:
16
10
2024
pubmed:
16
10
2024
entrez:
16
10
2024
Statut:
aheadofprint
Résumé
To investigate factors influencing long-term utilization and disposal patterns of cryopreserved semen straws in oncological patients. This retrospective study included all men who cryopreserved semen due to cancer between October 1993 and December 2021. To assess non-used cryopreserved sperm straws, we investigated the following parameters: cryopreserved semen and usage for fertility treatments versus disposal, summarized by total non-used cases. A Kaplan-Meier curve was used to describe last usage and disposal requests over a 15-year analysis. A Log-rank test was applied to compare between age and paternal status categories. The cohort consisted of 445 patients. Of these, 55 patients utilized thawed semen for fertility treatments, and 65 opted for disposals, leaving 325 patients who neither used nor disposed of their cryopreserved straws. Our findings revealed a distinct pattern based on age, with the youngest age group (< 25 years) exhibiting significantly lower utilization and disposal rates compared to older patient groups. Additionally, men without children exhibited significantly fewer disposal requests compared to fathers. The median cryopreserved straws were 10 (interquartile range, 6 to 17), while the median used straws were only 2 (interquartile range, 2 to 6). Our study brings attention to the additional and needless burden of preservation from both patient and preserved straw perspectives. Implementing a policy based on a cost-effective approach, incorporating time and straw limits, and considering demographic characteristics, could enhance efficiency and necessitate patient consent before preservation.
Identifiants
pubmed: 39412622
doi: 10.1007/s10815-024-03290-8
pii: 10.1007/s10815-024-03290-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, et al. Global cancer statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
doi: 10.3322/caac.21660
pubmed: 33538338
Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749–68.
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75.
doi: 10.1016/S0140-6736(17)33326-3
pubmed: 29395269
pmcid: 5879496
Gatta G, Zigon G, Capocaccia R, Coebergh JW, Desandes E, et al. Survival of European children and young adults with cancer diagnosed 1995–2002. Eur J Cancer. 2009;45(6):992–1005.
doi: 10.1016/j.ejca.2008.11.042
pubmed: 19231160
Hamre H, Kiserud CE, Ruud E, Thorsby PM, Fosså SD. Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study. Pediatr Blood Cancer. 2012;59(2):271–7.
doi: 10.1002/pbc.23363
pubmed: 22021108
Oktay K, Oktem O. Fertility preservation medicine: a new field in the care of young cancer survivors. Pediatr Blood Cancer. 2009;53(2):267–73.
doi: 10.1002/pbc.22003
pubmed: 19301406
Barak S. Fertility preservation in male patients with cancer. Best Pract Res Clin Obstet Gynaecol. 2019;55:59–66.
doi: 10.1016/j.bpobgyn.2018.12.004
pubmed: 30744950
Caponecchia L, Cimino G, Sacchetto R, Fiori C, Sebastianelli A, et al. Do malignant diseases affect semen quality? Sperm parameters of men with cancers. Andrologia. 2016;48(3):333–40.
doi: 10.1111/and.12451
pubmed: 26173956
Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36(19):1994–2001.
doi: 10.1200/JCO.2018.78.1914
pubmed: 29620997
Lambertini M, Peccatori FA, Demeestere I, Amant F, Wyns C, et al. electronic address: clinicalguidelines@esmo.org. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO clinical practice guidelines. Ann Oncol. 2020;31(12):1664–78.
Schlegel PN, Sigman M, Collura B, De Jonge CJ, Eisenberg ML, et al. Diagnosis and treatment of infertility in men: AUA/ASRM guideline part II. J Urol. 2021;205(1):44–51.
doi: 10.1097/JU.0000000000001520
pubmed: 33295258
Bitan R, Suissa T, Gat I. Long-term sperm preservation: exploring the clinical, economic, and ethical dimensions. Isr Med Assoc J. 2024;26(7):447–51.
pubmed: 39082456
Lackamp N, Wilkemeyer I, Jelas I, Keller U, Bullinger L, et al. Survey of long-term experiences of sperm cryopreservation in oncological and non-oncological patients: usage and reproductive outcomes of a large monocentric cohort. Front Oncol. 2021;5(11):772809.
doi: 10.3389/fonc.2021.772809
Tang W, Deng C, Gao J, Tian S, Wei N, et al. An evaluation of the population characteristics, semen quality, and utilization status of autologous sperm cryopreservation and fertility preservation in for 662 patients: a 6-year monocentric retrospective study. Basic Clin Androl. 2022;32(1):18.
doi: 10.1186/s12610-022-00169-5
pubmed: 36324079
pmcid: 9629882
Chung JP, Haines CJ, Kong GW. Sperm cryopreservation for Chinese male cancer patients: a 17-year retrospective analysis in an assisted reproductive unit in Hong Kong. Hong Kong Med J. 2013;19(6):525–30.
pubmed: 24141859
Vomstein K, Reiser E, Pinggera GM, Toerzsoek P, Deininger S, et al. Sperm banking before gonadotoxic treatment: is it worth the effort? Asian J Androl. 2021;23(5):490–4.
doi: 10.4103/aja.aja_16_21
pubmed: 33818523
pmcid: 8451482
Ferrari S, Paffoni A, Reschini M, Noli S, Dallagiovanna C, et al. Variables affecting long-term usage rate of sperm samples cryopreserved for fertility preservation in cancer patients. Andrology. 2021;9(1):204–11.
doi: 10.1111/andr.12894
pubmed: 32814364
Bitan R, Magnezi R, Kedem A, Avraham S, Youngster M, et al. Autologous sperm usage after cryopreservation-the crucial impact of patients’ characteristics. Andrology. 2024;12(3):527–37.
doi: 10.1111/andr.13502
pubmed: 37528799
Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500–10.
doi: 10.1200/JCO.2013.49.2678
pubmed: 23715580
pmcid: 5321083
Nangia AK, Krieg SA, Kim SS. Clinical guidelines for sperm cryopreservation in cancer patients. Fertil Steril. 2013;100(5):1203–9.
doi: 10.1016/j.fertnstert.2013.08.054
pubmed: 24182555
Rives N, Courbière B, Almont T, Kassab D, Berger C, et al. What should be done in terms of fertility preservation for patients with cancer? The French 2021 guidelines. Eur J Cancer. 2022;173:146–66.
doi: 10.1016/j.ejca.2022.05.013
pubmed: 35932626
Gat I, Toren A, Hourvitz A, Raviv G, Band G, et al. Sperm preservation by electroejaculation in adolescent cancer patients. Pediatr Blood Cancer. 2014;61(2):286–90.
doi: 10.1002/pbc.24752
pubmed: 24000134
Ogouma L, Berthaut I, Lévy R, Hamid RH, Prades M, et al. Testicular sperm extraction (TESE) outcomes in the context of malignant disease: a systematic review. Asian J Androl. 2022;24(6):584–90.
doi: 10.4103/aja2021129
pubmed: 35259785
pmcid: 9809488
van Casteren NJ, van Santbrink EJ, van Inzen W, Romijn JC, Dohle GR. Use rate and assisted reproduction technologies outcome of cryopreserved semen from 629 cancer patients. Fertil Steril. 2008;90(6):2245–50.
doi: 10.1016/j.fertnstert.2007.10.055
pubmed: 18191846
Bizet P, Saias-Magnan J, Jouve E, Grillo JM, Karsenty G, et al. Sperm cryopreservation before cancer treatment: a 15-year monocentric experience. Reprod Biomed Online. 2012;24(3):321–30.
doi: 10.1016/j.rbmo.2011.11.015
pubmed: 22285245
Neal MS, Nagel K, Duckworth J, Bissessar H, Fischer MA, et al. Effectiveness of sperm banking in adolescents and young adults with cancer: a regional experience. Cancer. 2007;110(5):1125–9.
doi: 10.1002/cncr.22889
pubmed: 17647219
Johnson MD, Cooper AR, Jungheim ES, Lanzendorf SE, Odem RR, et al. Sperm banking for fertility preservation: a 20-year experience. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):177–82.
doi: 10.1016/j.ejogrb.2013.06.021
pubmed: 23870186
van der Kaaij MA, van Echten-Arends J, Heutte N, Meijnders P, Abeilard-Lemoisson E, et al. Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: an EORTC-GELA Lymphoma Group cohort study. Hum Reprod. 2014;29(3):525–33.
doi: 10.1093/humrep/det430
pubmed: 24345581
Sonnenburg DW, Brames MJ, Case-Eads S, Einhorn LH. Utilization of sperm banking and barriers to its use in testicular cancer patients. Support care cancer. 2015;23(9):2763–8.
doi: 10.1007/s00520-015-2641-9
pubmed: 25680764
Bitan R, Kedem A, Avraham S, Youngster M, Yerushalmi G, et al. Cryopreserved testicular spermatozoa among patients with azoospermia. J Assist Reprod Genet. 2024;41(8):2099–105.
doi: 10.1007/s10815-024-03167-w
pubmed: 38878197
Gat I, Li N, Yasovich N, Antes R, Kuznyetsov V, et al. Sperm DNA fragmentation index does not correlate with blastocyst euploidy rate in egg donor cycles. Gynecol Endocrinol. 2018;34(3):212–6.
doi: 10.1080/09513590.2017.1379500
pubmed: 28972428